Birch Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Birch Capital Management's RMD Position: Q1 2026 in Review
Birch Capital Management increased its ResMed (RMD) stake by 0.41% in Q1 2026, buying an estimated $27.4K and bringing the position to 27,009 shares worth $6.06M. The position accounts for 3.18% of the portfolio, ranked #11.
Birch Capital Management first reported a position in RMD in Q4 2019 and has held it in 26 quarters since. The position peaked at $9.73M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Birch Capital Management held 27,009 shares of ResMed worth $6.06M as of Q1 2026.
- Birch Capital Management bought 110 ResMed shares in Q1 2026, an estimated $27.4K.
- ResMed made up 3.18% of Birch Capital Management's portfolio in Q1 2026, its #11 holding.
- Birch Capital Management first reported a position in ResMed in Q4 2019 and has held it in 26 quarters since.
- Birch Capital Management's ResMed position peaked at $9.73M in Q3 2025.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Birch Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.